A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Journal of Ocular Pharmacology and Therapeutics - United States
doi 10.1089/jop.2015.0148
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Mary Ann Liebert Inc